Page last updated: 2024-12-10

argipressin, beta-mercapto(beta,beta)-cyclopentamethylenepropionic acid(1)-ile(2,4)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

argipressin, beta-mercapto(beta,beta)-cyclopentamethylenepropionic acid(1)-Ile(2,4)-: RN refers to (L-Ile-D-Ile-L-Arg)-isomer; vasopressin and vasopressin (2) receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080966
MeSH IDM0158958

Synonyms (16)

Synonym
d(ch2)5-ile(2,4)-arg(8)-avp
d(ch2)5-ile-ile-arg-avp
ileu(2)ileu(4)avp
agripressin, beta-mercapto(beta,beta)-cyclopentamethylenepropionic(1)-isoleucine(2,4)-
d(ch2)5-d-ileu(2)-ileu(4)-avp
vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-l-isoleucine-4-d-isoleucine-8-l-arginine-
103529-95-9
1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2,4-ile-argipressin
argipressin, beta-mercapto(beta,beta)-cyclopentamethylenepropionic acid(1)-ile(2,4)-
d(ch2)5[d-ile2,ile4]vp
beta-mercapto-beta,beta,cyclopentamethylenepropionyl[d-ile2,ile4]avp
d(ch2)5[d-ile2,ile4]avp
gtpl2236
arginine vasopressin, (beta-mercapto)beta,beta-cyclopentamethylenepropionic acid(1)-ile(2,4)-
(2s)-n-[(2r)-1-[(2s)-2-[[(2s)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-sulfanylpropan-2-yl]-2-[[(2r,3r)-3-methyl-2-[[(2s)-2-[[(2s,3s)-3-methyl-2-[[2-(2-sulfanylidenecyclohexyl)acetyl]ami
Q27077000
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346453Human V2 receptor (Vasopressin and oxytocin receptors)2000Kidney international, Oct, Volume: 58, Issue:4
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's6 (60.00)18.2507
2000's1 (10.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]